{
    "organizations": [],
    "uuid": "6444f9226f5baf7eb05aa87d56d848d956186a60",
    "author": "",
    "url": "https://www.reuters.com/article/brief-syros-pharmaceuticals-reports-q4-l/brief-syros-pharmaceuticals-reports-q4-loss-per-share-0-58-idUSASC09RQI",
    "ord_in_thread": 0,
    "title": "BRIEF-Syros Pharmaceuticals Reports Q4 Loss Per Share $0.58",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 12, 2018 / 11:26 AM / in 8 minutes BRIEF-Syros Pharmaceuticals Reports Q4 Loss Per Share $0.58 Reuters Staff 1 Min Read March 12 (Reuters) - Syros Pharmaceuticals Inc: * SYROS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND HIGHLIGHTS RECENT ACCOMPLISHMENTS AND ANTICIPATED MILESTONES * Q4 LOSS PER SHARE $0.58 * Q4 EARNINGS PER SHARE VIEW $-0.57 â€” THOMSON REUTERS I/B/E/S * ANNOUNCED APPOINTMENT OF JOSEPH J. FERRA AS CHIEF FINANCIAL OFFICER * SYROS PHARMA - BELIEVES CASH, CASH EQUIVALENTS AS OF DEC 31, 2017 WILL BE SUFFICIENT TO ENABLE CO TO FUND PLANNED OPERATING EXPENSE, CAPEX INTO 2020 Source text for Eikon: Further company coverage:",
    "published": "2018-03-12T13:26:00.000+02:00",
    "crawled": "2018-03-12T13:40:28.024+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "minute",
        "pharmaceutical",
        "report",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "syros",
        "pharmaceutical",
        "inc",
        "syros",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "highlight",
        "recent",
        "accomplishment",
        "anticipated",
        "milestone",
        "q4",
        "loss",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "announced",
        "appointment",
        "joseph",
        "ferra",
        "chief",
        "financial",
        "officer",
        "syros",
        "pharma",
        "belief",
        "cash",
        "cash",
        "equivalent",
        "dec",
        "sufficient",
        "enable",
        "co",
        "fund",
        "planned",
        "operating",
        "expense",
        "capex",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}